Pre-Open Stock Movers 12/08: (LXRX) (SFIX) (SMAR) Higher; (PEN) (CONN) (MRNS) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
GrowGeneration Corp. (GRWG) Prices 5M Share Upsized Common Offering at $30/Sh
December 9, 2020 7:04 AM ESTGrowGeneration Corp. (NASDAQ: GRWG) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at an offering price of $30.00 per share (the "Offering"). GrowGen expects the gross proceeds from the Offering to be approximately $150 million, before deducting the underwriting... More
ATARA Biotherapeutics (ATRA) Prices 5.102M Share Common Offering at $24.50/Sh
December 9, 2020 6:11 AM ESTAtara Biotherapeutics, Inc. (NASDAQ: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced the pricing of an underwritten public offering of 5,102,041 shares of its common stock at a price to the public of $24.50 per share and, to... More
Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh
December 9, 2020 6:10 AM ESTSutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $21.00 per share. The gross proceeds... More
Marinus Pharma (MRNS) Prices 5M Share Common Offering for Gross Proceeds of $70M
December 8, 2020 9:44 AM ESTMarinus Pharmaceuticals, Inc. (NASDAQ: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing of an underwritten public offering of 5 million shares of its common stock for gross proceeds of $70 million, before deducting the underwriting discounts and commissions and other estimated offering expenses... More
